Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia

ClinicalTrials.gov ID: NCT02608697

Public ClinicalTrials.gov record NCT02608697. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 12:26 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this placebo-controlled, double-blind study is to assess the effect of several doses of CAT-2054 on LDL-C in hypercholesterolemic patients on a stable dose of high-intensity statin, and to evaluate the safety and tolerability of different doses of CAT-2054 for 4 weeks.

Study identification

NCT ID
NCT02608697
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Catabasis Pharmaceuticals
Industry
Enrollment
153 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 74 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2015 (Type not available)
Primary completion
May 2016 (Actual)
Completion
Jun 2016 (Actual)
Last update posted
Jun 20, 2017

2015 – 2016

United States locations

U.S. sites
34
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
Not listed Muscle Shoals Alabama 35662 —
Not listed Huntington Park California 90255 —
Not listed Lomita California 90717 —
Not listed Los Angeles California 90057 —
Not listed Brooksville Florida 34601 —
Not listed Hialeah Florida 33012 —
Not listed Jupiter Florida 33458 —
Not listed Pembroke Pines Florida 33026 —
Not listed Winter Park Florida 32792 —
Not listed Chicago Illinois 60607 —
Not listed Evanston Illinois 60201 —
Not listed Indianapolis Indiana 46260 —
Not listed Kansas City Kansas 66160 —
Not listed Louisville Kentucky 40213 —
Not listed Auburn Maine 04210 —
Not listed Troy Michigan 48098 —
Not listed Las Vegas Nevada 89123 —
Not listed New York New York 10029 —
Not listed Rochester New York 14609 —
Not listed Cincinnati Ohio 45219 —
Not listed Cincinnati Ohio 45227 —
Not listed Cincinnati Ohio 45246 —
Not listed Columbus Ohio 43213 —
Not listed Franklin Ohio 45005 —
Not listed Lyndhurst Ohio 44124 —
Not listed Marion Ohio 43302 —
Not listed Willoughby Hills Ohio 44094 —
Not listed Mt. Pleasant South Carolina 29464 —
Not listed Summerville South Carolina 29485 —
Not listed Houston Texas 77036 —
Not listed Houston Texas 77074 —
Not listed Orem Utah 84058 —
Not listed Richmond Virginia 23294 —
Not listed Olympia Washington 98502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02608697, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 20, 2017 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02608697 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →